Alvotech (ALVO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Alvotech (ALVO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.05B, listed on NASDAQ, employing roughly 1,012 people, carrying a beta of 0.21 to the broader market. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. Led by Lisa Graver, public since 2022-06-16.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for ALVO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.